HIV 1 News and Research

RSS

Scientists discover new mechanism for inadequate immune defense against chronic viral infection

Scientists at the University of Basel discovered a fundamental new mechanism explaining the inadequate immune defense against chronic viral infection. These results may open up new avenues for vaccine development. They have been published in the journal "Science Immunology".

21 Oct 2016

New research examines use of nanotechnology to improve delivery of drugs to HIV patients

New research led by the University of Liverpool aims to improve the administration and availability of drug therapies to HIV patients through the use of nanotechnology.

21 Oct 2016

UCSF researchers find active HIV in tissue samples of patients treated with antiretrovirals

While successful treatment of HIV with antiretroviral medications leads to undetectable levels of virus in the blood, controls the disease and leads to much longer lifespans, scientists know that HIV continues to reside in tissues.

21 Oct 2016

Zika virus infections modify viral and human genetic material, research finds

Researchers at University of California San Diego School of Medicine have discovered that Zika virus infection leads to modifications of both viral and human genetic material.

20 Oct 2016

Study estimates impact of six common healthcare-associated infections

A study published today by PLOS Medicine, estimates the combined burden of six healthcare-associated infections as being higher than that of diseases such as influenza, HIV/AIDS and tuberculosis together.

19 Oct 2016

Women report experimental vaginal ring for HIV prevention did not negatively affect sexual experience

Most women who used an experimental vaginal ring for HIV prevention report that the physical act of sex was largely unaffected by using the product, which is inserted monthly for continuous wear.

18 Oct 2016

New discovery helps explain why HIV infection increases risk for active tuberculosis

The HIV virus increases the potency of the tuberculosis bacterium (Mtb) by affecting a central function of the immune system.

18 Oct 2016

Scientists develop software package to predict chemical properties of molecules

Scientists from MIPT's Research Center for Molecular Mechanisms of Aging and Age-Related Diseases together with Inria research center, Grenoble, France have developed a software package called Knodle to determine an atom's hybridization, bond orders and functional groups' annotation in molecules.

17 Oct 2016

Scientists at NIH and Emory University induce sustained remission in SIV-infected monkeys

Scientists at the National Institutes of Health and Emory University have experimentally induced sustained remission of SIV, the simian form of HIV, in infected monkeys.

14 Oct 2016

Many Canadian territories restrict access to medications for treating hepatitis C, study finds

A study conducted by Canadian and Australian researchers shows that nearly everywhere in Canada, the provinces and territories impose obstacles to reimbursement of new direct-acting antivirals (DAA) to treat hepatitis C by because of their cost.

14 Oct 2016

New amfAR report highlights role of health plans, health care purchasers in curbing domestic HIV epidemic

Today, amfAR, The Foundation for AIDS Research released a new report, “Curbing the HIV Epidemic by Supporting Effective Engagement in HIV Care: Recommendations for Health Plans and Health Care Purchasers,” which highlights the critical role of health plans and health care purchasers, including Medicaid and Medicare programs, marketplaces, and employers, in moving the nation toward ending the domestic HIV epidemic.

14 Oct 2016

WHO: Countries need to move much faster to prevent, detect and treat TB to meet global targets

New data published by the World Health Organization (WHO) in its 2016 Global Tuberculosis (TB) Report show that countries need to move much faster to prevent, detect and treat the disease if they are to meet global targets.

14 Oct 2016

ASCO issues new global guideline on screening for cervical cancer

The American Society of Clinical Oncology today issued a new global guideline on screening for cervical cancer, one of the leading causes of cancer related death among women worldwide.

14 Oct 2016

Migrants pre-screened for TB pose negligible risk of infection, new study finds

Tuberculosis (TB) incidence in the UK has declined over the past 4 years, with fewer numbers of new migrants diagnosed with the disease. A new study, published in The Lancet finds that migrants arriving on visas to the UK from countries at high risk of TB and who were pre-screened for TB, pose a negligible risk of onwards infection, despite being at increased risk of developing TB themselves.

13 Oct 2016

Genome engineering-based methods pave way for new treatment of patients with sickle cell disease

A team of physicians and laboratory scientists has taken a key step toward a cure for sickle cell disease, using CRISPR-Cas9 gene editing to fix the mutated gene responsible for the disease in stem cells from the blood of affected patients.

12 Oct 2016

New study of Phase II Alzheimer's drug pipeline reveals more ways to combat disease

A new analysis of the Phase II Alzheimer's drug pipeline, conducted by ResearchersAgainstAlzheimer's, revealed 57 new Alzheimer's drugs. According to the analysis, nearly twice as many mechanisms of action are being tested in Phase II than in Phase III clinical trials.

7 Oct 2016

Study provides important insights into impact of late HIV testing

An estimated 1.2 million people live with HIV in the United States, with nearly 13 percent being unaware of their infection.

7 Oct 2016

Many gay and bisexual men unaware that PrEP medication may reduce HIV risk

Only four in 10 gay and bisexual men in Baltimore without HIV are aware that pre-exposure prophylaxis medication (PrEP) may significantly reduce their risk of contracting the virus, even those who had recently visited a doctor or been tested for a sexually transmitted disease, new Johns Hopkins Bloomberg School of Public Health research suggests.

5 Oct 2016

Researchers confirm long persistence of Zika virus in semen and reveal its presence within spermatozoa

Recent work has shown that Zika virus persists in semen for up to 6 months after infection. In a correspondence published in The Lancet Infectious Diseases, the researchers, in addition to confirming its long persistence in semen (in this case for more than 130 days, i.e., over 4 months), reveal the presence of the virus even within spermatozoa.

4 Oct 2016

Antibody protection may help control infection caused by TB bacteria

A study led by investigators from the Ragon Institute of MGH, MIT and Harvard finds evidence that antibody protection may help control infection with the bacteria that causes tuberculosis (TB).

4 Oct 2016

HIV 1 News and Research

Scientists discover new mechanism for inadequate immune defense against chronic viral infection

New research examines use of nanotechnology to improve delivery of drugs to HIV patients

UCSF researchers find active HIV in tissue samples of patients treated with antiretrovirals

Zika virus infections modify viral and human genetic material, research finds

Study estimates impact of six common healthcare-associated infections

Women report experimental vaginal ring for HIV prevention did not negatively affect sexual experience

New discovery helps explain why HIV infection increases risk for active tuberculosis

Scientists develop software package to predict chemical properties of molecules

Scientists at NIH and Emory University induce sustained remission in SIV-infected monkeys

Many Canadian territories restrict access to medications for treating hepatitis C, study finds

New amfAR report highlights role of health plans, health care purchasers in curbing domestic HIV epidemic

WHO: Countries need to move much faster to prevent, detect and treat TB to meet global targets

ASCO issues new global guideline on screening for cervical cancer

Migrants pre-screened for TB pose negligible risk of infection, new study finds

Genome engineering-based methods pave way for new treatment of patients with sickle cell disease

New study of Phase II Alzheimer's drug pipeline reveals more ways to combat disease

Study provides important insights into impact of late HIV testing

Many gay and bisexual men unaware that PrEP medication may reduce HIV risk

Researchers confirm long persistence of Zika virus in semen and reveal its presence within spermatozoa

Antibody protection may help control infection caused by TB bacteria

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News